New Succinimides with Potent Anticancer Activity: Synthesis, Activation of Stress Signaling Pathways and Characterization of Apoptosis in Leukemia and Cervical Cancer Cells

• Published in: International journal of molecular sciences 2021-04, Vol.22 (9), p.4318
• Main Authors: Cieślak, Marcin, Napiórkowska, Mariola, Kaźmierczak-Barańska, Julia, Królewska-Golińska, Karolina, Hawrył, Anna, Wybrańska, Iwona, Nawrot, Barbara
• Format: Article
• Language: English
• Subjects: Alkanolamines; Alkylamines; Antitumor activity; Apoptosis; Cancer therapies; Cell death; Cervical cancer; Cervix; Cytotoxicity; Deoxyribonucleic acid; DNA; DNA microarrays; Drug development; Endothelial cells; Gene expression; Genes; Hydrochlorides; Imides; Immunomodulation; Kinases; Leukemia; Mitochondria; Multiple myeloma; NF-κB protein; NMR; Nuclear magnetic resonance; Plasmids; Signal transduction; Succinimides
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22094318

Based on previously identified dicarboximides with significant anticancer and immunomodulatory activities, a series of 26 new derivatives were designed and synthesized by the Diels-Alder reaction between appropriate diene and maleimide or hydroxymaleimide moieties. The resulting imides were functionalized with alkanolamine or alkylamine side chains and subsequently converted to their hydrochlorides. The structures of the obtained compounds were confirmed by 1H and 13C NMR and by ESI MS spectral analysis. Their cytotoxicity was evaluated in human leukemia (K562, MOLT4), cervical cancer (HeLa), and normal endothelial cells (HUVEC). The majority of derivatives exhibited high to moderate cytotoxicity and induced apoptosis in K562 cells. Microarray gene profiling demonstrated upregulation of proapoptotic genes involved in receptor-mediated and mitochondrial cell death pathways as well as antiapoptotic genes involved in NF-kB signaling. Selected dicarboximides activated JNK and p38 kinases in leukemia cells, suggesting that MAPKs may be involved in the regulation of apoptosis. The tested dicarboximides bind to DNA as assessed by a plasmid DNA cleavage protection assay. The selected dicarboximides offer new scaffolds for further development as anticancer drugs.